现在是时候重新思考阿尔茨海默病药物开发策略了吗?
Is it time to rethink the Alzheimer’s disease drug development strategy by targeting its silent phase?
Benoit Souchet, Mickael Audrain, Baptiste Billoir, Laurent Lecanu, Satoru Tada, Jérôme Braudeau
中国神经再生研究(英文版) . 2018, (2): 224 -225 .  DOI: 10.4103/1673-5374.226389